Search results
Results From The WOW.Com Content Network
OPKO Health (OPK) delivered earnings and revenue surprises of -100% and 3.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Disappointing Q1 results weighed on the healthcare stock. For premium support please call: 800-290-4726 more ways to reach us
OPKO Health, Inc. (NASDAQ:OPK) insiders have had a fantastic week as stock increased 5.1%, and they haven't stopped buying Simply Wall St October 30, 2022 at 5:04 AM
Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q3 2024 Earnings Call Nov 07, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK". [ 2 ]
OPKO Health (OPK) closed the most recent trading day at $3.22, moving -0.92% from the previous trading session.
OPKO Health's (OPK) second-quarter results benefit from continued strength in its Pharmaceuticals segment. OPKO Health (OPK) Stock Gains 2.1% Despite Q2 Earnings Miss Skip to main content
For premium support please call: 800-290-4726 more ways to reach us